SCHEDULE 13G: Nantahala Capital Partners Discloses 5.78% Passive Stake in DarioHealth Corp.
Beneficial Ownership Disclosure
Nantahala Capital Partners Limited Partnership has filed a Schedule 13G, reporting a passive beneficial ownership of 5.7771% in DarioHealth Corp.'s common stock as of February 27, 2025.
Summary
- Nantahala Capital Partners Limited Partnership (Nantahala) has filed a Schedule 13G with the SEC, indicating beneficial ownership in DarioHealth Corp.
- As of February 27, 2025, Nantahala beneficially owns 2,511,120 shares of DarioHealth Corp. common stock.
- This ownership represents 5.7771% of the total class of securities outstanding.
- The calculation of the percentage is based on 41,537,016 shares outstanding and includes 1,929,655 shares that Nantahala may acquire within sixty days through the exercise of securities.
- Nantahala holds shared voting power and shared dispositive power over all 2,511,120 shares.
- The filing certifies that the securities were not acquired and are not held for the purpose or effect of changing or influencing the control of DarioHealth Corp.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently convey positive or negative sentiment regarding the issuer's performance or prospects. It is a neutral regulatory filing.
Future Outlook
This document does not contain any forward-looking statements or guidance regarding the issuer's future performance or outlook.
Industry Context
This filing indicates a significant passive investment by Nantahala Capital Partners in DarioHealth Corp., a company operating in the digital health sector. Such disclosures are common for institutional investors crossing the 5% ownership threshold, signaling their belief in the company's long-term prospects without seeking active control.
Stakeholder Impact
- Shareholders: The disclosure of a significant passive stake by an institutional investor like Nantahala Capital Partners may be viewed positively, indicating investor confidence in DarioHealth Corp. It also provides transparency regarding major ownership positions.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date of event which requires filing of this statement (beneficial ownership threshold crossed). |
| 03/06/2025 | Date of signing the Schedule 13G statement by Nantahala Capital Management, LLC. |
Keywords
DarioHealth Corp., Nantahala Capital Partners, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment, Passive Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.